HeartWare International Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:HeartWare International Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7129
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc, is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that consists of a ventricular assist device (VAD) or blood pumps, surgical tools and patient accessories. The system provides circulatory support for patients in advanced stage of heart failure. The company offers products for the treatment of Class IIIB and IV patients who suffer from advanced heart failure. The company sells its products through distributors throughout US, Europe and other countries. HeartWare is headquartered in Framingham, Massachusetts, the US.

HeartWare International Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HeartWare International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
HeartWare International Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
HeartWare International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
HeartWare International Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
HeartWare International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
HeartWare International Inc, Medical Equipment, Deal Details 10
Partnerships 10
HeartWare International Enters Into Co-Development Agreement With Dualis MedTech 10
Equity Offering 11
HeartWare International Completes Public Offering Of Common Stock For US$149 Million 11
Debt Offering 13
HeartWare Announces Private Placement of Notes Due 2021 for USD66 Million 13
Acquisition 14
Medtronic Acquires HeartWare International for USD1.1 Billion 14
HeartWare International To Acquire CircuLite For US$350 Million 16
HeartWare International Completes Acquisition Of World Heart, Developer Of Implantable Ventricular Assist Devices, For US$8 Million 18
HeartWare International Inc – Key Competitors 20
HeartWare International Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Product News 22
May 04, 2017: Medtronic Mechanical Circulatory Support (formerly HeartWare) Expands Recall for Ventricular Assist Device Controllers and DC Adapter 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
HeartWare International Inc, Medical Equipment, Key Facts 2
HeartWare International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
HeartWare International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
HeartWare International Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
HeartWare International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
HeartWare International Inc, Deals By Market, 2012 to YTD 2018 8
HeartWare International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
HeartWare International Enters Into Co-Development Agreement With Dualis MedTech 10
HeartWare International Completes Public Offering Of Common Stock For US$149 Million 11
HeartWare Announces Private Placement of Notes Due 2021 for USD66 Million 13
Medtronic Acquires HeartWare International for USD1.1 Billion 14
HeartWare International To Acquire CircuLite For US$350 Million 16
HeartWare International Completes Acquisition Of World Heart, Developer Of Implantable Ventricular Assist Devices, For US$8 Million 18
HeartWare International Inc, Key Competitors 20
HeartWare International Inc, Other Locations 21
HeartWare International Inc, Subsidiaries 21

List of Figures
HeartWare International Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
HeartWare International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
HeartWare International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
HeartWare International Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
HeartWare International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
HeartWare International Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
HeartWare International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
HeartWare International Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[HeartWare International Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Impel NeuroPharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delive …
  • FlightSafety International Inc:企業の戦略・SWOT・財務分析
    FlightSafety International Inc - Strategy, SWOT and Corporate Finance Report Summary FlightSafety International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sojitz Corp (2768):石油・ガス:M&Aディール及び事業提携情報
    Summary Sojitz Corp (Sojitz) is a diversified general trading group. The group through its subsidiaries and affiliates holds interest in machinery; energy and metals; chemicals and functional materials; and consumer lifestyle businesses. It distributes automobiles and aircraft; develops power projec …
  • Ablynx NV (ABLX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ablynx NV (Ablynx) is a biopharmaceutical company that focuses on developing Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional properties of nat …
  • lululemon athletica inc.:企業の戦略・SWOT・財務情報
    lululemon athletica inc. - Strategy, SWOT and Corporate Finance Report Summary lululemon athletica inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Leprino Foods Company:企業の戦略・SWOT・財務情報
    Leprino Foods Company - Strategy, SWOT and Corporate Finance Report Summary Leprino Foods Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Edmond De Rothschild (Suisse) S.A.:企業の戦略・SWOT・財務分析
    Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Mayne Pharma Group Ltd (MYX):企業の財務・戦略的SWOT分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …
  • Salvatore Ferragamo SpA (SFER):企業の財務・戦略的SWOT分析
    Salvatore Ferragamo SpA (SFER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Kelly Services, Inc.:企業の戦略・SWOT・財務分析
    Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Galardi Group, Inc.:企業の戦略・SWOT・財務情報
    Galardi Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Galardi Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Premier Inc (PINC):医療機器:M&Aディール及び事業提携情報
    Summary Premier Inc (Premier) is a provider of healthcare solutions. It is an alliance of hospitals, health systems, physicians and other healthcare providers in the US. The alliance enables the owners to share services and programs aimed at improving the quality and cost-effectiveness of clinical o …
  • CCP Technologies Ltd (CT1):医療機器:M&Aディール及び事業提携情報
    Summary CCP Technologies Ltd (CCP), formerly Agenix Ltd, is a technology company that offers business-to-business hardware and software solutions. The company develops Internet of Things’ solutions for management of computers, smart phones, sensors and diverse equipment. It offers business hardware …
  • Clarion Co Ltd:企業の戦略的SWOT分析
    Clarion Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Jordan Phosphate Mines Co. Plc.:企業の戦略・SWOT・財務情報
    Jordan Phosphate Mines Co. Plc. - Strategy, SWOT and Corporate Finance Report Summary Jordan Phosphate Mines Co. Plc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Prognomix Inc:企業の製品パイプライン分析
    Summary Prognomix Inc (Prognomix) is a personalized medicine company that develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. The company’s products include PGX IR01, PGx GR01, PGx CD01, PGx IR02 …
  • Sigma-Tau HealthScience USA, Inc:戦略・SWOT・企業財務分析
    Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report Summary Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Integra LifeSciences Holdings Corporation:企業のM&A・事業提携・投資動向
    Integra LifeSciences Holdings Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Integra LifeSciences Holdings Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • JHL Biotech Inc (6540):企業の財務・戦略的SWOT分析
    Summary JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab, biosimilar dornase alfa, biosimilar bevacizumab, biosimilar trastuz …
  • Rexel S.A.:企業の戦略・SWOT・財務分析
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆